739 related articles for article (PubMed ID: 23255218)
21. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
[TBL] [Abstract][Full Text] [Related]
22. Bromodomain proteins regulate human cytomegalovirus latency and reactivation allowing epigenetic therapeutic intervention.
Groves IJ; Jackson SE; Poole EL; Nachshon A; Rozman B; Schwartz M; Prinjha RK; Tough DF; Sinclair JH; Wills MR
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619107
[TBL] [Abstract][Full Text] [Related]
23. Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV.
Niu Q; Liu Z; Alamer E; Fan X; Chen H; Endsley J; Gelman BB; Tian B; Kim JH; Michael NL; Robb ML; Ananworanich J; Zhou J; Hu H
J Clin Invest; 2019 Jul; 129(8):3361-3373. PubMed ID: 31329163
[TBL] [Abstract][Full Text] [Related]
24. ZASC1 stimulates HIV-1 transcription elongation by recruiting P-TEFb and TAT to the LTR promoter.
Bruce JW; Reddington R; Mathieu E; Bracken M; Young JA; Ahlquist P
PLoS Pathog; 2013 Oct; 9(10):e1003712. PubMed ID: 24204263
[TBL] [Abstract][Full Text] [Related]
25. Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein.
Jin H; Li D; Sivakumaran H; Lor M; Rustanti L; Cloonan N; Wani S; Harrich D
mBio; 2016 Jul; 7(4):. PubMed ID: 27381288
[TBL] [Abstract][Full Text] [Related]
26. Bromodomain and Extraterminal Inhibition by JQ1 Produces Divergent Transcriptional Regulation of Suppressors of Cytokine Signaling Genes in Adipocytes.
Mota de Sá P; Richard AJ; Stephens JM
Endocrinology; 2020 Feb; 161(2):. PubMed ID: 31875887
[TBL] [Abstract][Full Text] [Related]
27. BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses.
Belkina AC; Nikolajczyk BS; Denis GV
J Immunol; 2013 Apr; 190(7):3670-8. PubMed ID: 23420887
[TBL] [Abstract][Full Text] [Related]
28. Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.
Lambert JP; Picaud S; Fujisawa T; Hou H; Savitsky P; Uusküla-Reimand L; Gupta GD; Abdouni H; Lin ZY; Tucholska M; Knight JDR; Gonzalez-Badillo B; St-Denis N; Newman JA; Stucki M; Pelletier L; Bandeira N; Wilson MD; Filippakopoulos P; Gingras AC
Mol Cell; 2019 Feb; 73(3):621-638.e17. PubMed ID: 30554943
[TBL] [Abstract][Full Text] [Related]
29. BET bromodomain inhibition as a novel strategy for reactivation of HIV-1.
Banerjee C; Archin N; Michaels D; Belkina AC; Denis GV; Bradner J; Sebastiani P; Margolis DM; Montano M
J Leukoc Biol; 2012 Dec; 92(6):1147-54. PubMed ID: 22802445
[TBL] [Abstract][Full Text] [Related]
30. NF-κB signaling activation via increases in BRD2 and BRD4 confers resistance to the bromodomain inhibitor I-BET151 in U937 cells.
Hishiki K; Akiyama M; Kanegae Y; Ozaki K; Ohta M; Tsuchitani E; Kaito K; Yamada H
Leuk Res; 2018 Nov; 74():57-63. PubMed ID: 30300821
[TBL] [Abstract][Full Text] [Related]
31. Bromodomain and Extra-terminal (BET) Protein Inhibitors Suppress Chondrocyte Differentiation and Restrain Bone Growth.
Niu N; Shao R; Yan G; Zou W
J Biol Chem; 2016 Dec; 291(52):26647-26657. PubMed ID: 27821592
[TBL] [Abstract][Full Text] [Related]
32. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.
Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J
J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242
[TBL] [Abstract][Full Text] [Related]
33. Splicing Factor 3B Subunit 1 Interacts with HIV Tat and Plays a Role in Viral Transcription and Reactivation from Latency.
Kyei GB; Meng S; Ramani R; Niu A; Lagisetti C; Webb TR; Ratner L
mBio; 2018 Nov; 9(6):. PubMed ID: 30401776
[TBL] [Abstract][Full Text] [Related]
34. Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma.
Song S; Li Y; Xu Y; Ma L; Pool Pizzi M; Jin J; Scott AW; Huo L; Wang Y; Lee JH; Bhutani MS; Weston B; Shanbhag ND; Johnson RL; Ajani JA
Mol Oncol; 2020 Jun; 14(6):1410-1426. PubMed ID: 32175692
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms of HIV latency.
Cary DC; Fujinaga K; Peterlin BM
J Clin Invest; 2016 Feb; 126(2):448-54. PubMed ID: 26731470
[TBL] [Abstract][Full Text] [Related]
36. BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency.
Lu P; Shen Y; Yang H; Wang Y; Jiang Z; Yang X; Zhong Y; Pan H; Xu J; Lu H; Zhu H
Sci Rep; 2017 Nov; 7(1):16646. PubMed ID: 29192216
[TBL] [Abstract][Full Text] [Related]
37. FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency.
Huang H; Santoso N; Power D; Simpson S; Dieringer M; Miao H; Gurova K; Giam CZ; Elledge SJ; Zhu J
J Biol Chem; 2015 Nov; 290(45):27297-27310. PubMed ID: 26378236
[TBL] [Abstract][Full Text] [Related]
38. BRD4 coordinates recruitment of pause release factor P-TEFb and the pausing complex NELF/DSIF to regulate transcription elongation of interferon-stimulated genes.
Patel MC; Debrosse M; Smith M; Dey A; Huynh W; Sarai N; Heightman TD; Tamura T; Ozato K
Mol Cell Biol; 2013 Jun; 33(12):2497-507. PubMed ID: 23589332
[TBL] [Abstract][Full Text] [Related]
39. An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription.
Mousseau G; Clementz MA; Bakeman WN; Nagarsheth N; Cameron M; Shi J; Baran P; Fromentin R; Chomont N; Valente ST
Cell Host Microbe; 2012 Jul; 12(1):97-108. PubMed ID: 22817991
[TBL] [Abstract][Full Text] [Related]
40. Brd4 is essential for IL-1β-induced inflammation in human airway epithelial cells.
Khan YM; Kirkham P; Barnes PJ; Adcock IM
PLoS One; 2014; 9(4):e95051. PubMed ID: 24759736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
